Association between genetics variants and clinical outcomes in patients with left ventricular assist device
P/LP variants were associated with early RVF, suggesting that genetic testing may inform RVF risk stratification and perioperative management.
Authors
- Elizabeth Silver (ORCID: https://orcid.org/0009-0000-5605-0646)
- Kimberly N. Hong (ORCID: https://orcid.org/0000-0003-3293-138X)
- Q. Bui
- Marcus A. Urey (ORCID: https://orcid.org/0000-0001-8311-5003)
- Hao Tran (ORCID: https://orcid.org/0000-0001-6102-5939)
- Mark J. Kearns
- Eric D. Adler
- Victor Pretorius
Institutions
- University of California San Diego (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100477
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Heart Association
- Pfizer
- AstraZeneca
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Ionis Pharmaceuticals